110 related articles for article (PubMed ID: 38859856)
21. LRPPRC promotes glycolysis by stabilising LDHA mRNA and its knockdown plus glutamine inhibitor induces synthetic lethality via m
Yu Y; Deng H; Wang W; Xiao S; Zheng R; Lv L; Wang H; Chen J; Zhang B
Clin Transl Med; 2024 Feb; 14(2):e1583. PubMed ID: 38372449
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.
Qiao Y; Wang B; Yan Y; Niu L
Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485
[TBL] [Abstract][Full Text] [Related]
23. CircCD44 plays oncogenic roles in triple-negative breast cancer by modulating the miR-502-5p/KRAS and IGF2BP2/Myc axes.
Li J; Gao X; Zhang Z; Lai Y; Lin X; Lin B; Ma M; Liang X; Li X; Lv W; Lin Y; Zhang N
Mol Cancer; 2021 Oct; 20(1):138. PubMed ID: 34696797
[TBL] [Abstract][Full Text] [Related]
24. The Novel Circular RNA Circ-PGAP3 Promotes the Proliferation and Invasion of Triple Negative Breast Cancer by Regulating the miR-330-3p/Myc Axis.
He D; Yang X; Kuang W; Huang G; Liu X; Zhang Y
Onco Targets Ther; 2020; 13():10149-10159. PubMed ID: 33116597
[TBL] [Abstract][Full Text] [Related]
25. The circRNA circIFI30 promotes progression of triple-negative breast cancer and correlates with prognosis.
Xing L; Yang R; Wang X; Zheng X; Yang X; Zhang L; Jiang R; Ren G; Chen J
Aging (Albany NY); 2020 Jun; 12(11):10983-11003. PubMed ID: 32497020
[TBL] [Abstract][Full Text] [Related]
26. IGF2BP3 enhances the mRNA stability of E2F3 by interacting with LINC00958 to promote endometrial carcinoma progression.
Wang C; Kong F; Ma J; Miao J; Su P; Yang H; Li Q; Ma X
Cell Death Discov; 2022 Jun; 8(1):279. PubMed ID: 35676262
[TBL] [Abstract][Full Text] [Related]
27. CircRNA hsa_circ_0006220 acts as a tumor suppressor gene by regulating miR-197-5p/CDH19 in triple-negative breast cancer.
Shi Y; Han T; Liu C
Ann Transl Med; 2021 Aug; 9(15):1236. PubMed ID: 34532373
[TBL] [Abstract][Full Text] [Related]
28. IGF2BP3 loss inhibits cell progression by upregulating has_circRNA_103820, and hsa_circRNA_103820-encoded peptide inhibits cell progression by inactivating the AKT pathway in lung cancer.
Zhou J; Yao L; Su Y; Tian L
Chem Biol Drug Des; 2024 Feb; 103(2):e14473. PubMed ID: 38378275
[TBL] [Abstract][Full Text] [Related]
29. hsa_circ_0000231 Promotes colorectal cancer cell growth through upregulation of CCND2 by IGF2BP3/miR-375 dual pathway.
Zhang W; Wang B; Lin Y; Yang Y; Zhang Z; Wang Q; Zhang H; Jiang K; Ye Y; Wang S; Shen Z
Cancer Cell Int; 2022 Jan; 22(1):27. PubMed ID: 35033075
[TBL] [Abstract][Full Text] [Related]
30. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract][Full Text] [Related]
31. Circular RNA circ-ERBB2 Elevates the Warburg Effect and Facilitates Triple-Negative Breast Cancer Growth by the MicroRNA 136-5p/Pyruvate Dehydrogenase Kinase 4 Axis.
Huang Y; Zheng S; Lin Y; Ke L
Mol Cell Biol; 2021 Sep; 41(10):e0060920. PubMed ID: 34370552
[TBL] [Abstract][Full Text] [Related]
32. RNA N6-methyladenosine reader IGF2BP3 interacts with MYCN and facilitates neuroblastoma cell proliferation.
Zhu K; Gao T; Wang Z; Zhang L; Tan K; Lv Z
Cell Death Discov; 2023 May; 9(1):151. PubMed ID: 37156775
[TBL] [Abstract][Full Text] [Related]
33. CircSNX25 mediated by SP1 promotes the carcinogenesis and development of triple-negative breast cancer.
Gao H; Tuluhong D; Li X; Zhu Y; Xu C; Wang J; Li H; Wang S; Ding W
Cell Signal; 2023 Sep; 109():110776. PubMed ID: 37331414
[TBL] [Abstract][Full Text] [Related]
34. circRNA N6-methyladenosine methylation in preeclampsia and the potential role of N6-methyladenosine-modified circPAPPA2 in trophoblast invasion.
Zhang Y; Yang H; Long Y; Zhang Y; Chen R; Shi J; Chen J
Sci Rep; 2021 Dec; 11(1):24357. PubMed ID: 34934095
[TBL] [Abstract][Full Text] [Related]
35. Circ_0098823 binding with IGF2BP3 regulates DNM1L stability to promote metastasis of hepatocellular carcinoma via mitochondrial fission.
Yan J; Wang X; Fan Z; Xu Y; Zhang Y; Liu Y; Guo L; Liu D
Apoptosis; 2024 Jun; 29(5-6):709-725. PubMed ID: 38459420
[TBL] [Abstract][Full Text] [Related]
36. IGF2BP3 prevent HMGB1 mRNA decay in bladder cancer and development.
Lv L; Wei Q; Zhang J; Dong Y; Shan Z; Chang N; Zhao Y; Bian P; Yi Q
Cell Mol Biol Lett; 2024 Mar; 29(1):39. PubMed ID: 38504159
[TBL] [Abstract][Full Text] [Related]
37. Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab.
Li J; Ma M; Yang X; Zhang M; Luo J; Zhou H; Huang N; Xiao F; Lai B; Lv W; Zhang N
Mol Cancer; 2020 Sep; 19(1):142. PubMed ID: 32917240
[TBL] [Abstract][Full Text] [Related]
38. circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression.
Chen B; Wei W; Huang X; Xie X; Kong Y; Dai D; Yang L; Wang J; Tang H; Xie X
Theranostics; 2018; 8(14):4003-4015. PubMed ID: 30083277
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of m6A Reader IGF2BP3 Inhibited Hypoxia-Induced Cell Migration and Angiogenesis by Regulating Hypoxia Inducible Factor-1α in Stomach Cancer.
Jiang L; Li Y; He Y; Wei D; Yan L; Wen H
Front Oncol; 2021; 11():711207. PubMed ID: 34621671
[TBL] [Abstract][Full Text] [Related]
40. METTL3/IGF2BP3-regulated m6A modification of HYOU1 confers doxorubicin resistance in breast cancer.
Zhou S; Sheng L; Zhang L; Zhang J; Wang L
Biochim Biophys Acta Gen Subj; 2024 Mar; 1868(3):130542. PubMed ID: 38103759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
